Our dataset° provides valuable insights into CLL, including but not limited to:
Estimated N CLL Patients
Average 1 year mortality %
Mean FU period
Average visits per patient
% Patients BTKI* treatment
Average age at diagnosis
Endpoints
* Bruton Tyrosine Kinase Inhibitor
Note that the estimated patient counts provided (prior to inclusion/exclusion criteria) are specific to our Belgian dataset. The LynxCare datasets continue to expand, encompassing real-world data from hospitals across Europe. Complete the request feasibility form linked above to discuss your study needs with one of our RWE experts.
The Value of Unstructured Data in the CLL Pathway
How LynxCare Can Help
° LynxCare datasets concern datasets within the LynxCare's European hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.